101 related articles for article (PubMed ID: 10814581)
1. Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein.
Bohl J; Das K; Dasgupta B; Vande Pol SB
Virology; 2000 May; 271(1):163-70. PubMed ID: 10814581
[TBL] [Abstract][Full Text] [Related]
2. Identification of a second transforming function in bovine papillomavirus type 1 E6 and the role of E6 interactions with paxillin, E6BP, and E6AP.
Das K; Bohl J; Vande Pol SB
J Virol; 2000 Jan; 74(2):812-6. PubMed ID: 10623743
[TBL] [Abstract][Full Text] [Related]
3. Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif.
Vande Pol SB; Brown MC; Turner CE
Oncogene; 1998 Jan; 16(1):43-52. PubMed ID: 9467941
[TBL] [Abstract][Full Text] [Related]
4. Requirement of E6AP and the features of human papillomavirus E6 necessary to support degradation of p53.
Cooper B; Schneider S; Bohl J; Jiang Yh; Beaudet A; Vande Pol S
Virology; 2003 Feb; 306(1):87-99. PubMed ID: 12620801
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance.
Zanier K; Charbonnier S; Baltzinger M; Nominé Y; Altschuh D; Travé G
J Mol Biol; 2005 Jun; 349(2):401-12. PubMed ID: 15890204
[TBL] [Abstract][Full Text] [Related]
6. Transformation by bovine papillomavirus type 1 E6 is independent of transcriptional activation by E6.
Ned R; Allen S; Vande Pol S
J Virol; 1997 Jun; 71(6):4866-70. PubMed ID: 9151888
[TBL] [Abstract][Full Text] [Related]
7. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton.
Tong X; Howley PM
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4412-7. PubMed ID: 9114003
[TBL] [Abstract][Full Text] [Related]
8. The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase.
Tong X; Salgia R; Li JL; Griffin JD; Howley PM
J Biol Chem; 1997 Dec; 272(52):33373-6. PubMed ID: 9407131
[TBL] [Abstract][Full Text] [Related]
9. Transformation by bovine papillomavirus type 1 E6 requires paxillin.
Wade R; Brimer N; Vande Pol S
J Virol; 2008 Jun; 82(12):5962-6. PubMed ID: 18385245
[TBL] [Abstract][Full Text] [Related]
10. Structural basis for hijacking of cellular LxxLL motifs by papillomavirus E6 oncoproteins.
Zanier K; Charbonnier S; Sidi AO; McEwen AG; Ferrario MG; Poussin-Courmontagne P; Cura V; Brimer N; Babah KO; Ansari T; Muller I; Stote RH; Cavarelli J; Vande Pol S; Travé G
Science; 2013 Feb; 339(6120):694-8. PubMed ID: 23393263
[TBL] [Abstract][Full Text] [Related]
11. Bovine papillomavirus type 1 E6-induced sensitization to apoptosis is distinct from its transforming activity.
Liu Z; Liu Y; Hong Y; Rapp L; Androphy EJ; Chen JJ
Virology; 2002 Apr; 295(2):230-7. PubMed ID: 12033781
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of transcriptional activation by the bovine papillomavirus type 1 E6.
Chen JJ; Hong Y; Androphy EJ
Virology; 1997 Sep; 236(1):30-6. PubMed ID: 9299614
[TBL] [Abstract][Full Text] [Related]
13. Interactions between E6, FAK, and GIT1 at paxillin LD4 are necessary for transformation by bovine papillomavirus 1 E6.
Brimer N; Wade R; Vande Pol S
J Virol; 2014 Sep; 88(17):9927-33. PubMed ID: 24942580
[TBL] [Abstract][Full Text] [Related]
14. Association of E6AP (UBE3A) with human papillomavirus type 11 E6 protein.
Brimer N; Lyons C; Vande Pol SB
Virology; 2007 Feb; 358(2):303-10. PubMed ID: 17023019
[TBL] [Abstract][Full Text] [Related]
15. The role of exogenous p53 and E6 oncoproteins in in vitro transformation by bovine papillomavirus type 4 (BPV-4): significance of the absence of an E6 ORF in the BPV-4 genome.
Scobie L; Jackson ME; Campo MS
J Gen Virol; 1997 Nov; 78 ( Pt 11)():3001-8. PubMed ID: 9367387
[TBL] [Abstract][Full Text] [Related]
16. Bovine papillomavirus E7 transformation function correlates with cellular p600 protein binding.
DeMasi J; Huh KW; Nakatani Y; Münger K; Howley PM
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11486-91. PubMed ID: 16081543
[TBL] [Abstract][Full Text] [Related]
17. The paxillin LD motifs.
Tumbarello DA; Brown MC; Turner CE
FEBS Lett; 2002 Feb; 513(1):114-8. PubMed ID: 11911889
[TBL] [Abstract][Full Text] [Related]
18. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein.
Chen JJ; Reid CE; Band V; Androphy EJ
Science; 1995 Jul; 269(5223):529-31. PubMed ID: 7624774
[TBL] [Abstract][Full Text] [Related]
19. Papillomavirus E6 oncoproteins.
Vande Pol SB; Klingelhutz AJ
Virology; 2013 Oct; 445(1-2):115-37. PubMed ID: 23711382
[TBL] [Abstract][Full Text] [Related]
20. Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP.
Be X; Hong Y; Wei J; Androphy EJ; Chen JJ; Baleja JD
Biochemistry; 2001 Feb; 40(5):1293-9. PubMed ID: 11170455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]